Bench to bedside
From bench to clinic: building technology clinicians trust
My path moved deliberately from discovery to translation: diabetes genetics at Lund, systems medicine at Stanford, global clinical development at Novo Nordisk, and then building and validating digital health tools.
Trust is the currency. Clinicians adopt a tool when the evidence is real, the reasoning is transparent, and the workflow is respected. Regulation is part of that trust, which is why I invested in FDA clinical investigator training and training in medical device regulations covering EU MDR, IVDR, and software as a medical device.
Build for the clinician in front of the patient, validate honestly, and the technology will reach the people it is meant to help.
This article is for general education and is not medical or professional advice. For guidance about your own health, talk with a qualified clinician.
Cite this article
Tojjar, D. (2024). From bench to clinic: building technology clinicians trust. Dr. Damon Tojjar. https://readingtheevidence.org/articles/bench-to-clinic/
This article is part of Dr. Tojjar's guide to Bench to bedside.